BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  AmpliPhi Biosciences Announces Stockholder Approval of Business Combination with C3J Therapeutics

  Approximately 94% of the shares voted at the special stockholder meeting voted in favor of the transaction, with each of the other related proposals also receiving sufficient votes for approval.

  May 8, 2019

   · 

  3 min read
• Deals

  AmerisourceBergen Declares Quarterly Dividend payable June 3, 2019

  The Board of Directors of AmerisourceBergen Corporation (NYSE: ABC) declared a quarterly cash dividend of $0.40 per common share, payable June 3, 2019, to stockholders of record at the close of business on May 20, 2019.

  May 8, 2019

   · 

  1 min read
• Business

  Immunocore appoints Dr Mohammed Dar as Head of Clinical Development and Chief Medical Officer

  Immunocore Limited, a leading T cell receptor (TCR) biotechnology company, today announces that Dr Mohammed Dar has been appointed as Head of Clinical Development and Chief Medical Officer, effective April 16, 2019.

  May 8, 2019

   · 

  3 min read